Segment Information (Tables)

9 Months Ended

Sep. 30, 2021

Net sales and operating profit by segment are as follows (in millions):

	Net Sales				Operating Profit
	Three Months Ended				Three Months Ended
	September 30,				September 30,
	2021		2020		2021			2020
Americas Orthopedics	$	1,009.4	$	1,033.2	$	422.2		$	452.1
EMEA		366.2		339.7		88.3			84.6
Asia Pacific		339.9		336.0		114.7			113.4
Americas Spine and Global Dental		208.5		220.4		27.8			39.3
Total	$	1,924.0	$	1,929.3
Corporate Functions						(151.2	)		(181.3	)
Inventory and manufacturing-related charges						(11.0	)		(2.3	)
Intangible asset amortization						(153.7	)		(149.7	)
Restructuring and other cost reduction initiatives						(23.3	)		(16.2	)
Quality remediation						(11.8	)		(10.0	)
Acquisition, integration, divestiture and related						(27.3	)		(9.1	)
Litigation						(43.6	)		(19.3	)
European Union Medical Device Regulation						(11.9	)		(2.0	)
Other charges						(4.3	)		(0.3	)
Operating profit					$	214.9		$	299.2

	Net Sales				Operating Profit (Loss)
	Nine Months Ended				Nine Months Ended
	September 30,				September 30,
	2021		2020		2021			2020
Americas Orthopedics	$	3,013.9	$	2,602.7	$	1,254.7		$	1,059.1
EMEA		1,108.2		915.1		269.8			213.5
Asia Pacific		1,022.5		876.4		346.4			284.4
Americas Spine and Global Dental		653.7		545.0		106.9			61.8
Total	$	5,798.3	$	4,939.2
Corporate Functions						(469.6	)		(574.7	)
Inventory and manufacturing-related charges						(13.0	)		(4.3	)
Intangible asset amortization						(463.8	)		(445.0	)
Goodwill and intangible asset impairment						(16.3	)		(645.0	)
Restructuring and other cost reduction initiatives						(64.9	)		(89.2	)
Quality remediation						(33.0	)		(35.8	)
Acquisition, integration, divestiture and related						(66.1	)		(15.7	)
Litigation						(53.3	)		(100.4	)
European Union Medical Device Regulation						(29.4	)		(19.1	)
Certain R&D agreements						(65.0	)	-
Other charges						(2.4	)		(18.1	)
Operating profit (loss)					$	701.0		$	(328.5	)